Pancreatic Cancer Research

ResearcherFred and Pamela Buffett Cancer CenterNo recent work listed

Bailee H. Sliker

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4686-4221; OpenAlex author ID A5047278765. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper

Papers 3

  1. The histone deacetylase inhibitor M344 as a multifaceted therapy for pancreatic cancer. Co-author DOI 10.1371/journal.pone.0273518↗
  2. HLA-B influences integrin beta-1 expression and pancreatic cancer cell migration. Co-author DOI 10.1016/j.yexcr.2020.111960↗
  3. Beta 2-microglobulin regulates amyloid precursor-like protein 2 expression and the migration of pancreatic cancer cells. Co-author DOI 10.1080/15384047.2019.1580414↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Joyce C. Solheim · 3 shared papers, 2019–2022 · strength 0.39
  2. Brittany J. Poelaert · 2 shared papers, 2019–2022 · strength 0.26
  3. Jennifer D. Black · 1 shared paper, 2022 · strength 0.15
  4. Shelby M. Knoche · 1 shared paper, 2022 · strength 0.15
  5. Alaina C. Larson · 1 shared paper, 2022 · strength 0.15
  6. Madeline T. Olson · 1 shared paper, 2022 · strength 0.15
  7. Ying Yan · 1 shared paper, 2022 · strength 0.15
  8. H. Carlo Maurer · 1 shared paper, 2020 · strength 0.13
  9. Hannah M. King · 1 shared paper, 2020 · strength 0.13
  10. Kenneth P. Olive · 1 shared paper, 2020 · strength 0.13
  11. Haley L. Peters · 1 shared paper, 2019 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.